1.Y Hu, L Wang , L Wang, XF Wu, XD Wu, Y Gu, Y Shu, Y Sun, Y Shen*, Q Xu*. Preferential cytotoxicity of bortezomib towards highly malignant human liposarcoma cells via suppression of MDR1 expression and function. Toxicol Appl Pharmacol 2015, 283(1):1-8.

2.L Guo, W Liu, T Lu, W Guo, J Gao, Q Luo, X Wu , Y Sun, X Wu, Y Shen*, Q Xu*. Decrease of functional activated T and B cells and treatment of glomerulonephitis in lupus-prone mice using a natural flavonoid astilbin. PLoS One 2015, 10: e0124002.

3. XY Fang, R Song, W Chen, YY Yang, YH Gu, YQ Shu, XD Wu, XF Wu, Y Sun*, Y Shen*, Q Xu*. PRL-3 promotes the malignant progression of melanoma via triggering dephosphorylation and cytoplasmic localization of NHERF1. J Invest Dermatol 2015; doi: 10.1038/jid.2015.154.

4. H Yuan, X Meng, W Guo, P Cai, W Li, Q Li, W Wang, Y Sun*, Q Xu*, Y Gu*. Transmembrane bound-IL-15-promoted epithelial-mesenchymal transition in renal cancer cells requires the Src-dependent Akt/GSK3beta/beta-catenin pathway. Neoplasia 2015; 17:410-420.

5. Wang X, Wang S, Hu C, Chen W, Shen Y, Wu X, Sun Y*, Xu Q. A new pharmacological effect of levornidazole: Inhibition of NLRP3 inflammasome activation. Biochem Pharmacol 2015; 97(2):178-88. 

6. L Zhang, X Cheng, Y Gao, J Bao, H Guan, RR Lu, H Yu*, Q Xu*, Y Sun*. Induction  of  ROS-independent  DNA  damage  by  curcumin  leads  to G2/M  cell  cycle  arrest  and  apoptosis  in  human  papillary  thyroid carcinoma BCPAP cells. Food Funct 2015; DOI: 10.1039/C5FO00681C. 

7. Li Q, Zhang X, Wang W, Li L, Xu Q, Wu X, Gu Y. CPT-11 activates NLRP3 inflammasome through JNK and NF-κB signalings.Toxicol Appl Pharmacol 2015;289(2):133-41. 
8. Wang X, Zhou Y, He S, Ouyang Z, Feng L, Shen Y, Wu X, Sun Y, Wu X, Xu Q. Obaculactone exerts a novel ameliorating effect on contact dermatitis through regulating T lymphocyte. Int Immunopharmacol 2015;28(1):1-9.

9. Guo W, Liu W, Jin B, Geng J, Li J, Ding H, Wu X, Xu Q, Sun Y, Gao J. Asiatic acid ameliorates dextran sulfate sodium-induced murine experimental colitis via suppressing mitochondria-mediated NLRP3 inflammasome activation.Int Immunopharmacol 2015;24(2):232-8. 

10. Yang B, Zhang M, Gao J, Li J, Fan L, Xiang G, Wang X, Wang X, Wu X, Sun Y, Wu X, Liang G, Shen Y, Xu Q. Small molecule RL71 targets SERCA2 at a novel site in the treatment of human colorectal cancer.Oncotarget 2015;6(35):37613-25. 


本网站由 钱程 同学维护 (chengtsien@gmail.com)                                                               © Molpharm Laboratory, 2013

Powered by PageAdmin CMS V3.0